Swine Reproductive and Respiratory Syndrome Vaccine Industry Research Report 2023

Swine Reproductive and Respiratory Syndrome Vaccine Industry Research Report 2023


Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.

Highlights

The global Swine Reproductive and Respiratory Syndrome Vaccine market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Boehringer ingelheim is the company with the largest market share, about 25 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Reproductive and Respiratory Syndrome Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Reproductive and Respiratory Syndrome Vaccine.
The Swine Reproductive and Respiratory Syndrome Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Swine Reproductive and Respiratory Syndrome Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Reproductive and Respiratory Syndrome Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.

Product Type Insights

Global markets are presented by Swine Reproductive and Respiratory Syndrome Vaccine type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Swine Reproductive and Respiratory Syndrome Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Swine Reproductive and Respiratory Syndrome Vaccine segment by Type

Active Vaccine
Inactivated Vaccines

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Swine Reproductive and Respiratory Syndrome Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Swine Reproductive and Respiratory Syndrome Vaccine market.
Swine Reproductive and Respiratory Syndrome Vaccine segment by Application

Government Tender
Market Sales

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Swine Reproductive and Respiratory Syndrome Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Reproductive and Respiratory Syndrome Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Swine Reproductive and Respiratory Syndrome Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Swine Reproductive and Respiratory Syndrome Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Reproductive and Respiratory Syndrome Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Swine Reproductive and Respiratory Syndrome Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Swine Reproductive and Respiratory Syndrome Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Swine Reproductive and Respiratory Syndrome Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size (2018-2029) & (US$ Million)
2.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (2018-2029)
2.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Average Price (2018-2029)
2.3 Swine Reproductive and Respiratory Syndrome Vaccine by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Active Vaccine
1.2.3 Inactivated Vaccines
2.4 Swine Reproductive and Respiratory Syndrome Vaccine by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Government Tender
2.4.3 Market Sales
3 Market Competitive Landscape by Manufacturers
3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue of Manufacturers (2018-2023)
3.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Manufacturers (2018-2023)
3.5 Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Product Type & Application
3.8 Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Date of Enter into This Industry
3.9 Global Swine Reproductive and Respiratory Syndrome Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 ASCENT CORPORATION
4.1.1 ASCENT CORPORATION Company Information
4.1.2 ASCENT CORPORATION Business Overview
4.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.1.5 ASCENT CORPORATION Recent Developments
4.2 Boehringer-Ingelheim
4.2.1 Boehringer-Ingelheim Company Information
4.2.2 Boehringer-Ingelheim Business Overview
4.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.2.5 Boehringer-Ingelheim Recent Developments
4.3 MSD Animal Health
4.3.1 MSD Animal Health Company Information
4.3.2 MSD Animal Health Business Overview
4.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.3.5 MSD Animal Health Recent Developments
4.4 SPAH
4.4.1 SPAH Company Information
4.4.2 SPAH Business Overview
4.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.4.5 SPAH Recent Developments
4.5 Ceva
4.5.1 Ceva Company Information
4.5.2 Ceva Business Overview
4.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.5.5 Ceva Recent Developments
4.6 Chengdu TECH-BANK Biological Products Co,.Ltd
4.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
4.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview
4.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments
4.7 ringpu
4.7.1 ringpu Company Information
4.7.2 ringpu Business Overview
4.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.7.5 ringpu Recent Developments
6.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
4.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
4.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview
4.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments
4.9 DAHUANONG
4.9.1 DAHUANONG Company Information
4.9.2 DAHUANONG Business Overview
4.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.9.5 DAHUANONG Recent Developments
4.10 CAVAC
4.10.1 CAVAC Company Information
4.10.2 CAVAC Business Overview
4.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
4.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
4.10.5 CAVAC Recent Developments
6.11 Komipharm
6.11.1 Komipharm Company Information
6.11.2 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.11.5 Komipharm Recent Developments
6.12 Agrovet
6.12.1 Agrovet Company Information
6.12.2 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.12.5 Agrovet Recent Developments
6.13 Bioveta
6.13.1 Bioveta Company Information
6.13.2 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.13.5 Bioveta Recent Developments
6.14 JINYU BIO-TECNOLOGY CO.,LTD
6.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
6.14.2 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments
6.15 Phibro Animal Health
6.15.1 Phibro Animal Health Company Information
6.15.2 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.15.5 Phibro Animal Health Recent Developments
6.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
6.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
6.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments
6.17 Zoetis
6.17.1 Zoetis Company Information
6.17.2 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.17.5 Zoetis Recent Developments
6.18 WINSUN BIO
6.18.1 WINSUN BIO Company Information
6.18.2 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.18.5 WINSUN BIO Recent Developments
6.19 PULIKE BIOLOGICAL ENGINERING,INC.
6.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
6.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Business Overview
6.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments
5 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Scenario by Region
5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2018-2029
5.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2018-2023
5.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2024-2029
5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2018-2029
5.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2018-2023
5.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2024-2029
5.4 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
5.4.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2029)
5.4.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
5.5.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2029)
5.5.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2029)
5.6.3 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
5.7.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2029)
5.7.3 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2029)
5.8.3 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2018-2029)
6.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2018-2029) & (K Units)
6.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2018-2029)
6.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2018-2029)
6.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2018-2029)
6.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2018-2029)
7 Segment by Application
7.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2018-2029)
7.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2018-2029) & (K Units)
7.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2018-2029)
7.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2018-2029)
6.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2018-2029)
7.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Swine Reproductive and Respiratory Syndrome Vaccine Value Chain Analysis
8.1.1 Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process
8.2 Swine Reproductive and Respiratory Syndrome Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
8.2.3 Swine Reproductive and Respiratory Syndrome Vaccine Customers
9 Global Swine Reproductive and Respiratory Syndrome Vaccine Analyzing Market Dynamics
9.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
9.2 Swine Reproductive and Respiratory Syndrome Vaccine Industry Drivers
9.3 Swine Reproductive and Respiratory Syndrome Vaccine Industry Opportunities and Challenges
9.4 Swine Reproductive and Respiratory Syndrome Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Swine Reproductive and Respiratory Syndrome Vaccine Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. ASCENT CORPORATION Company Information
Table 17. ASCENT CORPORATION Business Overview
Table 18. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 20. ASCENT CORPORATION Recent Developments
Table 21. Boehringer-Ingelheim Company Information
Table 22. Boehringer-Ingelheim Business Overview
Table 23. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 25. Boehringer-Ingelheim Recent Developments
Table 26. MSD Animal Health Company Information
Table 27. MSD Animal Health Business Overview
Table 28. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 30. MSD Animal Health Recent Developments
Table 31. SPAH Company Information
Table 32. SPAH Business Overview
Table 33. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 35. SPAH Recent Developments
Table 36. Ceva Company Information
Table 37. Ceva Business Overview
Table 38. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 40. Ceva Recent Developments
Table 41. Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
Table 42. Chengdu TECH-BANK Biological Products Co,.Ltd Business Overview
Table 43. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 45. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments
Table 46. ringpu Company Information
Table 47. ringpu Business Overview
Table 48. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 49. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 50. ringpu Recent Developments
Table 51. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
Table 52. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Business Overview
Table 53. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 54. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 55. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments
Table 56. DAHUANONG Company Information
Table 57. DAHUANONG Business Overview
Table 58. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 60. DAHUANONG Recent Developments
Table 61. CAVAC Company Information
Table 62. CAVAC Business Overview
Table 63. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 64. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 65. CAVAC Recent Developments
Table 66. Komipharm Company Information
Table 67. Komipharm Business Overview
Table 68. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 69. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 70. Komipharm Recent Developments
Table 71. Agrovet Company Information
Table 72. Agrovet Business Overview
Table 73. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 74. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 75. Agrovet Recent Developments
Table 76. Bioveta Company Information
Table 77. Bioveta Business Overview
Table 78. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 79. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 80. Bioveta Recent Developments
Table 81. JINYU BIO-TECNOLOGY CO.,LTD Company Information
Table 82. JINYU BIO-TECNOLOGY CO.,LTD Business Overview
Table 83. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 85. JINYU BIO-TECNOLOGY CO.,LTD Recent Developments
Table 86. Phibro Animal Health Company Information
Table 87. Phibro Animal Health Business Overview
Table 88. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 90. Phibro Animal Health Recent Developments
Table 91. ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
Table 92. ANHUI TIANKANG(GROUP)SHRES O., LTD Business Overview
Table 93. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 95. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments
Table 96. Zoetis Company Information
Table 97. Zoetis Business Overview
Table 98. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 100. Zoetis Recent Developments
Table 101. WINSUN BIO Company Information
Table 102. WINSUN BIO Business Overview
Table 103. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 105. WINSUN BIO Recent Developments
Table 106. PULIKE BIOLOGICAL ENGINERING,INC. Company Information
Table 107. PULIKE BIOLOGICAL ENGINERING,INC. Business Overview
Table 108. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 109. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
Table 110. PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments
Table 111. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 112. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2018-2023) & (K Units)
Table 113. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2018-2023)
Table 114. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2024-2029) & (K Units)
Table 115. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2024-2029)
Table 116. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 117. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2018-2023)
Table 118. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 119. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2024-2029)
Table 120. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2023) & (K Units)
Table 122. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2024-2029) & (K Units)
Table 123. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 124. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 125. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 126. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2023) & (K Units)
Table 127. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2024-2029) & (K Units)
Table 128. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 129. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 130. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2023) & (K Units)
Table 132. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2024-2029) & (K Units)
Table 133. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 134. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 135. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 136. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2023) & (K Units)
Table 137. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2024-2029) & (K Units)
Table 138. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 139. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 140. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 141. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2018-2023) & (K Units)
Table 142. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2024-2029) & (K Units)
Table 143. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 144. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 145. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2018-2023) & (K Units)
Table 146. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2024-2029) & (K Units)
Table 147. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2018-2023)
Table 148. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2024-2029)
Table 149. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 150. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 151. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2018-2023)
Table 152. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2024-2029)
Table 153. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2018-2023) & (USD/Unit)
Table 154. Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2024-2029) & (USD/Unit)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings